Nabil F. Saba

21.1k total citations · 6 hit papers
406 papers, 9.2k citations indexed

About

Nabil F. Saba is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nabil F. Saba has authored 406 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Oncology, 184 papers in Otorhinolaryngology and 149 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nabil F. Saba's work include Head and Neck Cancer Studies (178 papers), Lung Cancer Treatments and Mutations (82 papers) and Cancer Immunotherapy and Biomarkers (60 papers). Nabil F. Saba is often cited by papers focused on Head and Neck Cancer Studies (178 papers), Lung Cancer Treatments and Mutations (82 papers) and Cancer Immunotherapy and Biomarkers (60 papers). Nabil F. Saba collaborates with scholars based in United States, Italy and Spain. Nabil F. Saba's co-authors include Dong M. Shin, Conor Steuer, Fadlo R. Khuri, Kristin Higgins, Jonathan J. Beitler, Mark W. El‐Deiry, Robert I. Haddad, Sue S. Yom, Taofeek K. Owonikoko and Mayur D. Mody and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Nabil F. Saba

383 papers receiving 9.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

2017 497 citations Joshua Bauml, Tanguy Y. Seiwert et al. Journal of Clinical Oncology profile →
Head and neck cancer

2021 490 citations Robert I. Haddad, Nabil F. Saba et al. profile →
An update on larynx cancer

2016 484 citations Conor Steuer, Mark W. El‐Deiry et al. profile →
Management of locally recurrent nasopharyngeal carcinoma

2019 223 citations Antti Mäkitie, Juan P. Rodrigo et al. profile →
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer

2021 197 citations Mihir R. Patel, Dong M. Shin et al. profile →
Cancer metabolism and carcinogenesis

2024 58 citations Nabil F. Saba, Yong Teng et al. profile →

Peers

Countries citing papers authored by Nabil F. Saba

Since Specialization

Citations

This map shows the geographic impact of Nabil F. Saba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil F. Saba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil F. Saba more than expected).

Fields of papers citing papers by Nabil F. Saba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil F. Saba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil F. Saba. The network helps show where Nabil F. Saba may publish in the future.

Co-authorship network of co-authors of Nabil F. Saba

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil F. Saba. A scholar is included among the top collaborators of Nabil F. Saba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil F. Saba. Nabil F. Saba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell–Mediated Antitumor Immunity by Suppressing ER Stress–Associated THBS2 Signaling 2025 ·Cancer Research ·(unknown), Fanghui Chen, Zhenzhen Fu, Fan Yang, Nabil F. Saba, Yong Teng	1
2	Head and Neck Cancer Salvage Surgery in the Era of Immunotherapy and Beyond 2025 ·JAMA Otolaryngology–Head & Neck Surgery ·Nabil F. Saba, (unknown), (unknown), Karthik Rao, Robert P. Takes, Carol R. Bradford, Remco de Bree, Jonathan J. Beitler, Arlene A. Forastiere, Jan B. Vermorken, Anthea L. Hammond, Yong Teng, Nicole C. Schmitt, Alfio Ferlito	0
3	Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer 2024 ·Advances in Therapy ·Antti Mäkitie, Rasheed Omobolaji Alabi, Laura Pulkki-Råbäck, (unknown), Jonathan J. Beitler, Nabil F. Saba, Primož Strojan, Robert P. Takes, Orlando Guntinas‐Lichius, Alfio Ferlito	10
4	877P Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+ HNSCC 2024 ·Annals of Oncology ·Nabil F. Saba, (unknown), (unknown), (unknown), Tomasz Rutkowski, (unknown), (unknown), Massimo Di Maïo, Jasmaninder Singh Grewal, (unknown), (unknown), Huyuan Yang, Rishub K. Das, (unknown), (unknown), (unknown), Alexander Ulges, (unknown), (unknown), Uğur Şahin	4
5	A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma 2023 ·Targeted Oncology ·Albiruni Ryan Abdul Razak, Hung‐Ming Wang, Jang‐Yang Chang, Myung‐Ju Ahn, Pamela N. Münster, George R. Blumenschein, Benjamin Solomon, Wan‐Teck Lim, Ruey‐Long Hong, David G. Pfister, Nabil F. Saba, Se‐Hoon Lee, Carla van Herpen, Cornelia Quadt, Douglas Bootle, Lars Blumenstein, David Demanse, Jean‐Pierre Delord	10
6	489 Statin drugs augment tumor response to anti-PD-1 immune check point blockade in head and neck cancer patients 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Conor Steuer, Dong M. Shin, Nabil F. Saba, Nicole C. Schmitt	1
7	Iron, Ferroptosis, and Head and Neck Cancer 2023 ·International Journal of Molecular Sciences ·Yong Teng, Lixia Gao, Antti Mäkitie, Ewa Florek, Agata Czarnywojtek, Nabil F. Saba, Alfio Ferlito	8
8	Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer 2023 ·Head & Neck ·(unknown), Yan Zhan, Sangchoon Jeon, Deborah Watkins Bruner, Andrew H. Miller, Jennifer C. Felger, Evanthia C. Wommack, Nabil F. Saba, Kristin Higgins, Melinda L. Irwin, Rebecca Gary, Canhua Xiao	2
9	Progress and emerging strategies to preserve function in the treatment of sinonasal cancer 2023 ·Head & Neck ·K. Thomas Robbins, Ohad Ronen, Nabil F. Saba, Primož Strojan, Vincent Vander Poorten, Antti Mäkitie, Fernando López, Juan P. Rodrigo, Akihiro Homma, Ehab Y. Hanna, Alfio Ferlito	2
10	Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes 2023 ·Cancers ·Ronald C. Eldridge, Zhaohui Qin, Nabil F. Saba, Madelyn C. Houser, D. Neil Hayes, Andrew H. Miller, Deborah Watkins Bruner, Dean P. Jones, Canhua Xiao	2
11	Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma 2022 ·Clinical Cancer Research ·Charu Aggarwal, Nabil F. Saba, Alain P. Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T. Esser, Lily Cheng, Sonia Agrawal, Emily C. Jennings, Nicholas M. Durham, (unknown), (unknown), (unknown), (unknown), (unknown), Rakesh Kumar	26
12	The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers 2021 ·Cancer Research ·Zhengjia Chen, Chao Zhang, Jianhong Chen, Dongsheng Wang, (unknown), Carter Van Waes, Nabil F. Saba, Zhuo G. Chen, Zhong Chen	22
13	Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Ronald C. Eldridge, Karan Uppal, D. Neil Hayes, Matthew Ryan Smith, Xin Hu, Zhaohui Qin, Jonathan J. Beitler, Andrew H. Miller, Evanthia C. Wommack, Kristin Higgins, Dong M. Shin, Bryan C. Ulrich, David C. Qian, Nabil F. Saba, Deborah Watkins Bruner, Dean P. Jones, Canhua Xiao	5
14	Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck 2020 ·Clinical Cancer Research ·Dong M. Shin, Sreenivas Nannapaneni, Mihir R. Patel, Qiuying Shi, Yuan Liu, Zhengjia Chen, Amy Y. Chen, Mark W. El‐Deiry, Jonathan J. Beitler, Conor Steuer, Steven M. Roser, Adam M. Klein, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, Zhuo G. Chen, Nabil F. Saba	13
15	Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use 2019 ·Clinical Cancer Research ·Robert L. Ferris, Lisa Licitra, Jérôme Fayette, Caroline Even, George R. Blumenschein, Kevin J. Harrington, J. Guigay, Everett E. Vokes, Nabil F. Saba, Robert I. Haddad, S. Ramkumar, Jeffery S. Russell, Peter Brossart, Makoto Tahara, A. Dimitrios Colevas, Fernando Concha‐Benavente, Mark Lynch, Li Li, Maura L. Gillison	115
16	Establishment of a Database for Drug-Resistant Epilepsy, Isfahan Comprehensive Epilepsy Center, Iran 2018 ·SHILAP Revista de lepidopterología ·Jafar Mehvari Habibabadi, Nabil F. Saba, Majid Barekatain, Nasim Tabrizi, Navid Manouchehri	1
17	Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin 2017 ·Clinical Cancer Research ·Xu Wang, Jonathan J. Beitler, Wen‐Chin Huang, Guo Chen, Guoqing Qian, Kelly R. Magliocca, Mihir R. Patel, Amy Y. Chen, Jun Zhang, Sreenivas Nannapaneni, Sungjin Kim, Zhengjia Chen, Xingming Deng, Nabil F. Saba, Zhuo Georgia Chen, Jack L. Arbiser, Dong M. Shin	23
18	Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study breakdown → 2017 ·Journal of Clinical Oncology ·Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Francis P. Worden, Stephen V. Liu, Jill Gilbert, Nabil F. Saba, Jared Weiss, Lori J. Wirth, Ammar Sukari, Hyunseok Kang, Michael K. Gibson, Erminia Massarelli, Steven Powell, Amy Meister, Xinxin Shu, Jonathan D. Cheng, Robert I. Haddad	497
19	Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma 2014 ·Molecular Cancer Therapeutics ·Ning Jiang, Dongsheng Wang, Zhongliang Hu, Hyung Ju C. Shin, Guoqing Qian, Mohammad Aminur Rahman, Hongzheng Zhang, A.R.M. Ruhul Amin, Sreenivas Nannapaneni, Xiao‐Jing Wang, Zhengjia Chen, Gabriela Garcia, Gavin MacBeath, Dong M. Shin, Fadlo R. Khuri, Jun Ma, Zhuo G. Chen, Nabil F. Saba	50
20	Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies 2013 ·Clinical Cancer Research ·Dong M. Shin, Hongzheng Zhang, Nabil F. Saba, Amy Y. Chen, Sreenivas Nannapaneni, A.R.M. Ruhul Amin, Susan Müller, Melinda M. Lewis, Gabriel Sica, Scott A. Kono, Johann C. Brandes, William J. Grist, (unknown), Jonathan J. Beitler, Sufi M. Thomas, Zhengjia Chen, Hyung Ju C. Shin, Jennifer R. Grandis, Fadlo R. Khuri, Zhuo Georgia Chen	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact